Study finds semaglutide provides benefits for patients with obesity phenotype of heart failure and HFpEF

Researchers evaluated the efficacy of semaglutide in patients with the obesity phenotype of heart failure and preserved ejection fraction.

Breakthrough research unveils effects of ionizing radiation on cellular DNA

Recent release of the waste water from Japan’s Fukushima nuclear disaster stirred apprehension regarding the health implications of radiation exposure.

February 14, 2024

Boehringer Ingelheim, OSE Immunotherapeutics expand partnership beyond cancer

Boehringer Ingelheim is building on its collaboration with OSE Immunotherapeutics by investigating two clinical-stage oncology programs in cardio-renal-metabolic disease and adding a third preclinical cancer

May 23, 2024

New insights into daily health challenges faced by beauty service workers

The beauty service microbusiness industry in the United States -; such as the small, independently-owned nail salons found across the country -; is huge, with

October 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.